Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Current Leases (2019 - 2025)

Historic Current Leases for ImmunoTech (AIM) over the last 10 years, with Q3 2025 value amounting to $232000.0.

  • ImmunoTech's Current Leases changed 0.0% to $232000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $232000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $239000.0 for FY2024, which is 717.49% up from last year.
  • Per ImmunoTech's latest filing, its Current Leases stood at $232000.0 for Q3 2025, which was down 0.0% from $233000.0 recorded in Q2 2025.
  • ImmunoTech's 5-year Current Leases high stood at $240000.0 for Q1 2024, and its period low was $206000.0 during Q2 2023.
  • Its 3-year average for Current Leases is $228000.0, with a median of $232500.0 in 2024.
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1359.22% in 2024, then plummeted by 250.0% in 2025.
  • Over the past 3 years, ImmunoTech's Current Leases (Quarter) stood at $223000.0 in 2023, then grew by 7.17% to $239000.0 in 2024, then dropped by 2.93% to $232000.0 in 2025.
  • Its Current Leases was $232000.0 in Q3 2025, compared to $233000.0 in Q2 2025 and $234000.0 in Q1 2025.